lenalidomide has been researched along with Erythrocytosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cheng, CE; Cheng, M; Liang, B; Lor, M | 1 |
Liang, SH; Yeh, SP | 1 |
Arellano-Rodrigo, E | 1 |
3 other study(ies) available for lenalidomide and Erythrocytosis
Article | Year |
---|---|
TEMPI Syndrome With Progressive Telangiectasias Associated With Pulmonary Deterioration.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Bortezomib; Drug Therapy, Combination; Humans; Lenalidomide; Lung; Male; Middle Aged; Paraproteinemias; Polycythemia; Respiratory Insufficiency; Syndrome; Telangiectasis | 2020 |
Relapsed multiple myeloma as TEMPI syndrome with good response to salvage lenalidomide and dexamethasone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Polycythemia; Recurrence; Salvage Therapy; Syndrome; Telangiectasis | 2019 |
Case 23-2010: Unusual paraprotein effects in MGUS--treat or not?
Topics: Antineoplastic Agents; Humans; Kidney Diseases; Lenalidomide; Lymphangiectasis; Lymphangioma, Cystic; Paraproteinemias; Polycythemia; Thalidomide | 2010 |